Association between use of specialty dietary supplements and C-reactive protein concentrations. - Wikidata - wikimedia - TriplyDB

Association between use of specialty dietary supplements and C-reactive protein concentrations.

Association between use of specialty dietary supplements and C-reactive protein concentrations.

http://www.wikidata.org/entity/Q36606633

about

Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammation Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans.Study design and methods for the Breast Cancer and Exercise Trial in Alberta (BETA).Long-chain ω-3 fatty acid intake and endometrial cancer risk in the Women's Health Initiative Diet and biliary tract cancer risk in Shanghai, China Associations of Dietary Long-Chain ω-3 Polyunsaturated Fatty Acids and Fish Consumption With Endometrial Cancer Risk in the Black Women's Health Study Use of glucosamine and chondroitin in relation to mortality Factors Associated with Multiple Biomarkers of Systemic Inflammation.Use of glucosamine and chondroitin supplements and risk of colorectal cancer.Lifestyle factors and inflammation: associations by body mass index Specialty supplement use and biologic measures of oxidative stress and DNA damage.Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality.Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer.Garlic and Heart Disease.Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study.Associations of erythrocyte ω-3 fatty acids with biomarkers of ω-3 fatty acids and inflammation in breast tissue.Dietary n-3 polyunsaturated fatty acids, fish consumption, and endometrial cancer risk: a meta-analysis of epidemiological studies.Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study.Glucosamine use and risk of colorectal cancer: results from the Cancer Prevention Study II Nutrition Cohort.Vitamin E supplementation is associated with lower levels of C-reactive protein only in higher dosages and combined with other antioxidants: The Cooperative Health Research in the Region of Augsburg (KORA) F4 study.The favorable effects of garlic intake on metabolic profiles, hs-CRP, biomarkers of oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia: randomized, double-blind, placebo-controlled trial.

P2860

Q29247903-CDECE25C-16C6-49F1-8164-907035BA80D1 Q33724542-8B5AAF57-FF47-4EB1-BA85-DB0148D3FF9A Q35125783-EE6F0F4F-06EA-4419-911C-2DB9DAA47A33 Q35190303-33A92D5A-6218-4478-B3AD-84D735932550 Q35239530-A662E72F-6663-419F-A108-FF03D27348BB Q36306241-2FB6BF04-9912-4753-9C48-A1CB63CA990C Q36493619-59C861C7-34BB-4A48-9E1F-D246979A18DD Q36570336-11D3FE58-13A5-4A18-8E5D-1D7D974D1CC7 Q36655802-8C5FFF61-01DE-49D5-9D94-97AA3E1A80EC Q36900371-ED2572E4-D398-41F8-8CF8-1E0A1AC8C2ED Q36976367-CF178FDF-4495-4B42-8856-00776EFD4B5E Q37512685-5324F521-F7A5-445A-84BE-E62BD965DA4C Q37612576-43A822C8-9311-46CD-8D71-9E053CAA3C83 Q37653000-31D3C0FB-7D3C-4A6D-B03E-622F23A96C57 Q38695938-B248DFE9-3BF3-4EC8-AE75-482BE7FE088F Q39644887-53F32183-183D-442B-8704-1E1B109C1172 Q41618434-DB43EDB5-FA5B-4604-96A6-8A283DF8D065 Q47139456-24EA9C9D-4118-422D-AB28-406BF192037E Q47549931-ACB13835-C6DA-4216-988E-4EC580773450 Q50057188-DD6F579F-82E0-4FE4-B78C-52E0C56147BC Q50986522-69EDF8F3-D445-42B6-A8F2-31A78C027660 Q51314191-086A753A-A24C-429D-96C7-A6D51E77EEBD

P2860

Association between use of specialty dietary supplements and C-reactive protein concentrations.

http://www.wikidata.org/entity/Q36606633

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Association between use of spe ...... active protein concentrations.

@ast

Association between use of spe ...... active protein concentrations.

@en

type

label

Association between use of spe ...... active protein concentrations.

@ast

Association between use of spe ...... active protein concentrations.

@en

prefLabel

Association between use of spe ...... active protein concentrations.

@ast

Association between use of spe ...... active protein concentrations.

@en

P1433

Q36606633-B4AA39CF-446A-4817-A537-4C9AA064940E

P1476

Q36606633-F42F1693-3FFC-4338-B122-F88A08CF1FE4

P2093

Q36606633-06310D61-47FA-4838-AA3A-707FBC09E5FA

Q36606633-2DEE40C7-D5A6-4427-AC27-D611700F8784

Q36606633-E2132247-2C73-464A-8236-AA69CE90941F

P2860

Q36606633-0E82BFF7-6E8A-499F-A5A5-B30677DD27E7

Q36606633-178D089B-15B9-47BF-BD84-ED0B3E2BD965

Q36606633-1AD031B3-5764-47AE-A900-60F90475FBAA

Q36606633-1CCDEEB2-7716-488C-9F0D-EB809A447B1C

Q36606633-20EB9D21-9E17-48D4-BC94-5C462AFBCB37

Q36606633-24436F11-1144-43B6-9DB2-370D0CC692CE

Q36606633-2677E6E1-D29E-4D07-BB61-DD2B724299B1

Q36606633-26F0734B-9C4E-4AE3-B69F-DABE5824E8C2

Q36606633-283E9162-EAA2-4EAE-ABAC-57743E43EA1B

Q36606633-2E24FD48-CBE9-47EA-81E4-5B50DD40DECE

P304

Q36606633-5D7AB27B-1CC4-4445-BAD9-C7D82C71A9A9

P31

Q36606633-2BC64A51-FAE8-4729-A39B-97CAB7248D20

P356

Q36606633-AB9FE423-4050-49DB-87CA-1BD1EDBE9225

P407

Q36606633-D89B8E76-01CE-4394-9779-96166791AD77

P433

Q36606633-B3E81065-BF19-4EA4-B819-48148C8FE562

P478

Q36606633-00FE78C4-B213-4AC3-804C-76FEBD09C77C

P50

Q36606633-8E6249F4-7D4D-4D5D-A66A-C9DD32A8FF47

Q36606633-A65C0DF8-CB2E-4A52-965C-0866B0324BF7

Q36606633-E206345B-3C1B-4357-AA9C-A7798AE32054

P577

Q36606633-EA0DA8EB-B750-4E98-8DD6-B42B05AF4EA9

P5875

Q36606633-0040EDC8-8F87-4398-A83F-DA8A8C7F6CDC

P698

Q36606633-A42029EA-D58D-401B-840F-6B8F7BC60ED1

P932

Q36606633-980635D2-3277-40E0-8DCF-7E8B52628E59

P356

P1433

American Journal of Epidemiology

P1476

Association between use of spe ...... eactive protein concentrations

@en

P2093

Emily White

http://www.w3.org/2001/XMLSchema#string

Thomas L Vaughan

http://www.w3.org/2001/XMLSchema#string

Ulrike Peters

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT

Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States

The mechanism of action of aspirin

Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay

Lack of significant effect of low doses of aspirin on the concentrations of C-reactive protein in a group of individuals with atherothrombotic risk factors and vascular events

Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence

Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data.

P304

1002-1013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AJE/KWS186

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth D Kantor

Johanna W. Lampe

P577

2012-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233385070

http://www.w3.org/2001/XMLSchema#string

P698

23139249

http://www.w3.org/2001/XMLSchema#string

P932

3571242

http://www.w3.org/2001/XMLSchema#string